Perceptive Advisors’s Abeona Therapeutics Inc Warrant ABEOW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-659,636
| Closed | -$145K | – | 133 |
|
|
2019
Q3 | $145K | Hold |
659,636
| – | – | ﹤0.01% | 107 |
|
|
2019
Q2 | $620K | Hold |
659,636
| – | – | 0.01% | 92 |
|
|
2019
Q1 | $1.91M | Hold |
659,636
| – | – | 0.05% | 76 |
|
|
2018
Q4 | $1.27M | Hold |
659,636
| – | – | 0.05% | 80 |
|
|
2018
Q3 | $5.14M | Sell |
659,636
-600,000
| -48% | -$5.57M | 0.14% | 71 |
|
|
2018
Q2 | $12.8M | Hold |
1,259,636
| – | – | 0.34% | 56 |
|
|
2018
Q1 | $12M | Hold |
1,259,636
| – | – | 0.34% | 56 |
|
|
2017
Q4 | $14.6M | Hold |
1,259,636
| – | – | 0.48% | 48 |
|
|
2017
Q3 | $15.8M | Hold |
1,259,636
| – | – | 0.61% | 40 |
|
|
2017
Q2 | $4.29M | Hold |
1,259,636
| – | – | 0.22% | 68 |
|
|
2017
Q1 | $3.69M | Hold |
1,259,636
| – | – | 0.21% | 69 |
|
|
2016
Q4 | $3.78M | Hold |
1,259,636
| – | – | 0.27% | 66 |
|
|
2016
Q3 | $4.09M | Hold |
1,259,636
| – | – | 0.26% | 75 |
|
|
2016
Q2 | $1.07M | Hold |
1,259,636
| – | – | 0.07% | 97 |
|
|
2016
Q1 | $1.03M | Hold |
1,259,636
| – | – | 0.09% | 102 |
|
|
2015
Q4 | $1.66M | Hold |
1,259,636
| – | – | 0.12% | 78 |
|
|
2015
Q3 | $2.17M | Buy |
1,259,636
+9,636
| +0.8% | +$18.9K | 0.17% | 78 |
|
|
2015
Q2 | $2.25M | Buy |
+1,250,000
| New | +$2.79M | 0.14% | 96 |
|
Perceptive Advisors's ABEOW Position: Q4 2019 in Review
Perceptive Advisors sold out of Abeona Therapeutics Inc Warrant (ABEOW) in Q4 2019, closing a stake of 659,636 shares — an estimated $145K sold.
Perceptive Advisors first reported a position in ABEOW in Q2 2015 and held it in 18 quarters. The position peaked at $15.8M in Q3 2017. 0 funds tracked by Wall St. Rank hold ABEOW as of Q4 2019.
- Perceptive Advisors reported no remaining Abeona Therapeutics Inc Warrant position as of Q4 2019 after selling out during the quarter.
- Perceptive Advisors sold 659,636 Abeona Therapeutics Inc Warrant shares in Q4 2019, an estimated $145K.
- Perceptive Advisors first reported a position in Abeona Therapeutics Inc Warrant in Q2 2015 and held it in 18 quarters.
- Perceptive Advisors's Abeona Therapeutics Inc Warrant position peaked at $15.8M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Abeona Therapeutics Inc Warrant as of Q4 2019.
Based on Perceptive Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.